A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Yutaka Kawakami, S Eliyahu, C H Delgado et al. · Proceedings of the National Academy of Sciences · 1994 · 931 citations

Life Sciences, Immunology, Oncology +17

Immunoreactivity for A103, an Antibody to Melan-A (Mart-1), in Adrenocortical and Other Steroid Tumors

Klaus J. Busam, Kristin Iversen, Keren Coplan et al. · The American Journal of Surgical Pathology · 1998 · 242 citations

Medicine, Oncology, Pathology +17

A103

Achim A. Jungbluth, Klaus J. Busam, William L. Gerald et al. · The American Journal of Surgical Pathology · 1998 · 237 citations

Medicine, Oncology, Pathology +17

Expression of Melan-A (MART1) in Benign Melanocytic Nevi and Primary Cutaneous Malignant Melanoma

Klaus J. Busam, Yao‐Tseng Chen, Lloyd J. Old et al. · The American Journal of Surgical Pathology · 1998 · 236 citations

Medicine, Dermatology, Pathology +17

Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.

T. J. de Vries, A Fourkour, Th. Wobbes et al. · PubMed · 1997 · 191 citations

Medicine, Immunology, Oncology +17